09 Dec 2015

Intertek success at the Best of the Northern Biomedical Sector Awards

Manchester, United Kingdom – Intertek, a leading quality solutions provider to industries worldwide, has won the Technical Service Award category at the Best of the Northern Biomedical Sector Annual Awards.

Intertek was recognised for commitment, professionalism, innovation and success of technical service support to the biopharmaceutical and biomedical sectors, at the prestigious Bionow Awards, which showcase the best of businesses, products, technologies and individuals in the life sciences sector located in the north of Britain.

This Award follows the launch in September of Intertek’s 10,000 ft² bioanalytical and biopharmaceutical characterisation facility to deliver world-class scientific services to the growing pipeline of biologics medicines, such as monoclonal antibodies (mAbs) and recombinant proteins, which are being developed to treat heart disease, cancer-related diseases such as leukemia or melanoma and other chronic ailments. The new facility created a combined 30,000 ft2 of analytical and bioanalytical laboratories at Intertek’s Manchester-based Centre of Excellence for Biologics.

Ashleigh Wake of Intertek Life Sciences, Manchester said: “We are thrilled to have won the Bionow Technical Service Award, reflecting our commitment to the pharmaceutical sector. Our biopharma teams are committed to helping our globally based clients navigate the many technical challenges associated with bringing a biological medicine, such as monoclonal antibody therapeutics or biosimilar to market.”

Dr Geoff Davison, Chief Executive Officer of Bionow, commented: "The Bionow Annual Awards celebrate the best of the Northern biomedical sector and recognise the significant contribution that companies like Intertek have made to the Northern Powerhouse. We congratulate Intertek on their latest successful expansion which supports a wide range of biotech companies, not just in the United Kingdom, but also across the globe."

With over 15 years of services provision supporting biologics drug development, Intertek also provides pharmaceutical development and manufacturing support services spanning analysis, bioanalysis, formulation development, regulatory consultancy, auditing and supply chain management solutions from its network of offices and regulatory laboratories across the globe.


Further information:

Dr Lorna Kettle
Marketing Manager, Intertek Pharmaceutical Services
Tel.:+44 161 721 1476
Email: lorna.kettle@intertek.com

Joanne Merriweather
Intertek UK
Tel: +44 07786 525390

About Intertek

Intertek is a leading quality solutions provider to industries worldwide. From auditing and inspection, to testing, training, advisory, quality assurance and certification, Intertek adds value for its customers by helping improve the quality and safety of their products, assets and processes. With a network of more than 1,000 laboratories and offices and over 38,000 people in more than 100 countries, Intertek supports companies’ success in the global marketplace, by helping customers to meet end users’ expectations for safety, sustainability, performance, integrity and desirability in virtually any market worldwide. Visit www.intertek.com.